cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. It owns and operates consumer hemp-based CBD brands, such as cbdMD and Paw CBD. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. The company also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name. It distributes its products through its e-commerce Website, third party e-commerce sites, wholesalers, and various brick and mortar retailers in the United States. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was founded in 2015 and is headquartered in Charlotte, North Carolina.
IPO Year: 2017
Exchange: AMEX
Website: cbdmd.com
Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.
Cantor Fitzgerald resumed coverage of cbdMD with a rating of Neutral and set a new price target of $3.25 from $4.10 previously
Cantor Fitzgerald reiterated coverage of cbdMD with a rating of Neutral and set a new price target of $4.30 from $3.60 previously
10-Q - cbdMD, Inc. (0001644903) (Filer)
8-K - cbdMD, Inc. (0001644903) (Filer)
10-Q - cbdMD, Inc. (0001644903) (Filer)
SCHEDULE 13D - cbdMD, Inc. (0001644903) (Subject)
8-K - cbdMD, Inc. (0001644903) (Filer)
25-NSE - cbdMD, Inc. (0001644903) (Subject)
PRE 14A - cbdMD, Inc. (0001644903) (Filer)
10-Q - cbdMD, Inc. (0001644903) (Filer)
10-K/A - cbdMD, Inc. (0001644903) (Filer)
8-K - cbdMD, Inc. (0001644903) (Filer)
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
4 - cbdMD, Inc. (0001644903) (Issuer)
4 - cbdMD, Inc. (0001644903) (Issuer)
4 - cbdMD, Inc. (0001644903) (Issuer)
4 - cbdMD, Inc. (0001644903) (Issuer)
4 - cbdMD, Inc. (0001644903) (Issuer)
4 - cbdMD, Inc. (0001644903) (Issuer)
3 - cbdMD, Inc. (0001644903) (Issuer)
4 - cbdMD, Inc. (0001644903) (Issuer)
4 - cbdMD, Inc. (0001644903) (Issuer)
4 - cbdMD, Inc. (0001644903) (Issuer)
Live finance-specific insights
Announces Oasis Expands into Multiple New StatesCharlotte, North Carolina--(Newsfile Corp. - August 14, 2025) - cbdMD, Inc. (NYSE:YCBD), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, and Herbal Oasis today announced our financial results for the third quarter of fiscal year ended September 30, 2025. The Company delivered $4.6 million in revenue for the third quarter, down from $5.2 million in the prior year period. Operating loss increased from $0.4 million to $0.9 million. "While our third quarter results were not up to our standard, we have completed a major overhaul to our marketing team and dig
Charlotte, North Carolina--(Newsfile Corp. - August 12, 2025) - cbdMD, Inc. (NYSE:YCBD), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Thursday, August 14, 2025, to discuss the company's June 30, 2025 third quarter of fiscal year 2025 financial results and business progress.CONFERENCE CALL DETAILSThursday, August 14, 2025, 4:20 p.m. Eastern Time USA/Canada: 833-821-3524 International: 647-846-2919 Teleconference Replay dial in: USA/Canada: 855-669-9658 International: 412-317-0088 Replay Passcode: 5327882 Webcast/Webcast Replay link - available through August 15, 20
Successfully Completes Capital Structure Reset with Series A Preferred ConversionCharlotte, North Carolina--(Newsfile Corp. - May 15, 2025) - cbdMD, Inc. (NYSE:YCBD), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, and Herbal Oasis today announced our financial results for the second quarter of fiscal year ended September 30, 2025. The Company reported continued year-over-year improvements in both revenue and earnings while completing a transformative restructuring of its capital structure.The Company delivered $4.8 million in revenue for the second quarter, up from $4.3 million in the prior year peri
Charlotte, North Carolina--(Newsfile Corp. - May 9, 2025) - cbdMD, Inc. (NYSE:YCBD), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Thursday, May 15, 2025, to discuss the company's March 31, 2025 second quarter of fiscal year 2025 financial results and business progress.CONFERENCE CALL DETAILSThursday, May 15, 2025, 4:20 p.m. Eastern Time USA/Canada:833-821-3524 International:647-846-2919 Teleconference Replay dial in: USA/Canada:855-669-9658 International:412-317-0088 Replay Passcode:7254091 Webcast/Webcast Replay link - available through May 15, 2026: https://www.gowebc
Charlotte, North Carolina--(Newsfile Corp. - February 13, 2025) - (NYSE:YCBD) (NYSE:YCBDPA), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with its new functional mushroom brand ATRx Labs today announced our financial results for the first quarter of fiscal year ended December 31, 2024. The Company started fiscal 2025 with a historic quarter, achieving sequential revenue growth, positive net income and, although a loss from operations, the first ever quarter of positive non-GAAP Adjusted EBITDA. The Company generated Net Income of $15,000, an approximate $1 million improvement from the prior
Charlotte, North Carolina--(Newsfile Corp. - February 7, 2025) - cbdMD, Inc. (NYSE:YCBD) (NYSE:YCBDPA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Thursday, February 13, 2025, to discuss the company's December 31, 2024 first quarter of fiscal year 2025 financial results and business progress.CONFERENCE CALL DETAILSThursday, February 13, 2025, 4:20 p.m. Eastern TimeUSA/Canada:844-763-8274International:647-484-8814Teleconference Replay dial in:USA/Canada:855-669-9658International:412-317-0088Replay Passcode:7970691Webcast/Webcast Replay link - available through March 13, 202
Charlotte, North Carolina--(Newsfile Corp. - January 3, 2025) - cbdMD, Inc. (NYSE:YCBD) (NYSE:YCBD) ,one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with its new functional mushroom brand ATRx Labs, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated December 31, 2024, notifying the Company that it is no longer in compliance with an additional NYSE American continued listing standard. Specifically, the letter states that the Company is not in compliance with the continued listing standard set forth in Section 1003(a)(i) of the NYSE Amer
Finishes the year with a stronger cash position.Charlotte, North Carolina--(Newsfile Corp. - December 18, 2024) - cbdMD, Inc. (NYSE:YCBD) (NYSE:YCBDPA), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with its new functional mushroom brand ATRx Labs today announced our financial results for the full fiscal year ended September 30, 2024. For Fiscal 2024, we continued to make strong progress on our turnaround. The Company incurred a loss from operations of only $3.3 million, or a $19.1 million year-over-year improvement from the $22.9 million loss in the prior year. This is the second consecutive
Charlotte, North Carolina--(Newsfile Corp. - December 18, 2024) - cbdMD, Inc. (NYSE:YCBD) (NYSE:YCBDPA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Wednesday, December 18, 2024, to discuss the company's September 30, 2024 fourth quarter and fiscal year 2024 financial results and business progress.CONFERENCE CALL DETAILSWednesday, December 18, 2024, 4:20 p.m. Eastern TimeUSA/Canada:844-763-8274International:647-484-8814Teleconference Replay dial in:USA/Canada:855-669-9658International:412-317-0088Replay Passcode:5369354Webcast/Webcast Replay link - available through January
Charlotte, North Carolina--(Newsfile Corp. - December 17, 2024) - cbdMD, Inc. (NYSE:YCBD) (NYSE:YCBDPA), today announced that it has postponed the release of its financial results and conference call related to the fourth quarter and fiscal year ended September 30, 2024, which had previously been scheduled for December 17, 2024. cbdMD currently expects to issue its fourth quarter and fiscal year 2024 financial results after market close on Wednesday, December 18, 2024. The Company is delaying the release of financial results and the conference call because it needs additional time to complete its year-end reporting process. The Company currently expects to hold its conference call, on Wedne
Live Leadership Updates
Charlotte, North Carolina--(Newsfile Corp. - April 10, 2025) - cbdMD, Inc. (NYSE:YCBD) (NYSE:YCBDPA) (the "Company" or "cbdMD") one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with its functional mushroom brand ATRx Labs and emerging THC-infused seltzer brand Herbal Oasis announced today that at the Company's annual meeting of shareholders held on April 10, 2025, that its Common Stock holders and 8% Series A Cumulative Convertible Preferred Stock (the "Preferred Stock") holders approved the automatic conversion (the "Conversion") of shares of the Company's Preferred Stock into shares of the Comp
Charlotte, North Carolina--(Newsfile Corp. - June 22, 2023) - cbdMD (NYSE:YCBD), one of the nation's leading providers of premium cannabidiol (CBD) products, is delighted to announce the appointment of Dr. Lucille Vega as their new medical advisor. This collaboration marks an exciting chapter for both parties, as they play a pivotal role in educating the public about the numerous benefits of CBD and cbdMD's commitment to quality and transparency.As a brand that's renowned for its commitment to quality and innovation, cbdMD's comprehensive line of products spans across various categories and caters to a diverse range of consumer needs. By partnering with Dr. Vega, a highly qualified and passi
Charlotte, North Carolina--(Newsfile Corp. - January 11, 2023) - cbdMD, Inc. (NYSE:YCBD) (NYSE:YCBDPA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces the appointment of Shannon Charles as Chief Marketing Officer. Shannon is a veteran in health and wellness with over a decade of success in the Natural Product Industry. She has a proven record in driving growth across B&M retail, warehouse club stores, ecommerce, as well as international markets. Shannon's leadership has supported the successful brand stories of Naturade, NeoCell, and NutraNext, which the latter was ultimately acquired by The Clorox Co during her tenure. "We are thrilled to h
Martin Sumichrast resigns as CEO, Board MemberCharlotte, North Carolina--(Newsfile Corp. - June 13, 2022) - cbdMD, Inc. (NYSE:YCBD) (NYSE:YCBDPA), announced today that Martin Sumichrast has resigned as CEO and member of the Board of Directors, effective immediately. Board member Scott Stephen was named Board Chair and board member Scott Coffman, former co-CEO and the operating company founder, will consult with the Board of Directors in leading the company until a new CEO is named."We appreciate the years of service that Marty has given to our Company since its founding. However, we believe it is in the best interest of cbdMD, our employees, and our investors for him to step down." said Step
SCOTTSDALE, AZ / ACCESSWIRE / June 3, 2021 / Today CBD Life Sciences (OTC:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. is proud to announce that they have appointed Matthew McGee to serve as Chief Marketing Officer of the Company."I am over the top excited to assume the role of Chief Marketing Officer of CBD Life Sciences Inc," Mr. McGee said. "I look forward to growing the current success that CBD Life Sciences has achieved. I couldn't be anymore thankful for this wonderful opportunity, and I look forward to grow the company further, expand sales and bring in more revenue along with more customers as I have already started developing an amazingly effective strategic plan t
This live feed shows all institutional transactions in real time.
SC 13D/A - cbdMD, Inc. (0001644903) (Subject)
SC 13D/A - cbdMD, Inc. (0001644903) (Subject)
SC 13D/A - cbdMD, Inc. (0001644903) (Subject)
SC 13D/A - cbdMD, Inc. (0001644903) (Subject)
SC 13D/A - cbdMD, Inc. (0001644903) (Subject)
SC 13D/A - cbdMD, Inc. (0001644903) (Subject)
SC 13D/A - cbdMD, Inc. (0001644903) (Subject)
SC 13D/A - cbdMD, Inc. (0001644903) (Subject)
Fastest customizable press release news feed in the world
Announces Oasis Expands into Multiple New StatesCharlotte, North Carolina--(Newsfile Corp. - August 14, 2025) - cbdMD, Inc. (NYSE:YCBD), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, and Herbal Oasis today announced our financial results for the third quarter of fiscal year ended September 30, 2025. The Company delivered $4.6 million in revenue for the third quarter, down from $5.2 million in the prior year period. Operating loss increased from $0.4 million to $0.9 million. "While our third quarter results were not up to our standard, we have completed a major overhaul to our marketing team and dig
Charlotte, North Carolina--(Newsfile Corp. - August 12, 2025) - cbdMD, Inc. (NYSE:YCBD), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Thursday, August 14, 2025, to discuss the company's June 30, 2025 third quarter of fiscal year 2025 financial results and business progress.CONFERENCE CALL DETAILSThursday, August 14, 2025, 4:20 p.m. Eastern Time USA/Canada: 833-821-3524 International: 647-846-2919 Teleconference Replay dial in: USA/Canada: 855-669-9658 International: 412-317-0088 Replay Passcode: 5327882 Webcast/Webcast Replay link - available through August 15, 20
Charlotte, North Carolina--(Newsfile Corp. - June 24, 2025) - cbdMD, Inc. (NYSE:YCBD), a trusted leader in the wellness and cannabinoid industry, is proud to announce the retail debut of its Herbal Oasis Social Tonics at select Total Wine in Charlotte and surrounding North Carolina areas. The premium line of hemp-derived THC seltzers, first launched in late 2024, is now available across Total Wine stores across North Carolina.With strong initial placement in the Charlotte metro, the company is signaling its commitment to expanding Oasis Social Tonics throughout the state. Designed for mindful socialization, Herbal Oasis Social Tonics combine hemp-derived THC and CBG with a nootropic blend of
Charlotte, North Carolina--(Newsfile Corp. - May 21, 2025) - Herbal Oasis ("Oasis"), the hemp-derived THC-infused social seltzer redefining how people connect, unwind, and celebrate life, is proud to announce a new distribution partnership with Beverage South, a leading distributor serving much of the state of Georgia. Starting this month, Oasis will be available on shelves across Georgia as the brand continues its rapid expansion across the Southeast.Georgia marks the fourth state in just two months where Oasis has launched, following successful rollouts in Alabama, Florida, and North Carolina. The partnership with Beverage South significantly strengthens Oasis's presence in one of the regi
Successfully Completes Capital Structure Reset with Series A Preferred ConversionCharlotte, North Carolina--(Newsfile Corp. - May 15, 2025) - cbdMD, Inc. (NYSE:YCBD), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, and Herbal Oasis today announced our financial results for the second quarter of fiscal year ended September 30, 2025. The Company reported continued year-over-year improvements in both revenue and earnings while completing a transformative restructuring of its capital structure.The Company delivered $4.8 million in revenue for the second quarter, up from $4.3 million in the prior year peri
Charlotte, North Carolina--(Newsfile Corp. - May 9, 2025) - cbdMD, Inc. (NYSE:YCBD), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Thursday, May 15, 2025, to discuss the company's March 31, 2025 second quarter of fiscal year 2025 financial results and business progress.CONFERENCE CALL DETAILSThursday, May 15, 2025, 4:20 p.m. Eastern Time USA/Canada:833-821-3524 International:647-846-2919 Teleconference Replay dial in: USA/Canada:855-669-9658 International:412-317-0088 Replay Passcode:7254091 Webcast/Webcast Replay link - available through May 15, 2026: https://www.gowebc
Charlotte, North Carolina--(Newsfile Corp. - April 10, 2025) - cbdMD, Inc. (NYSE:YCBD) (NYSE:YCBDPA) (the "Company" or "cbdMD") one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with its functional mushroom brand ATRx Labs and emerging THC-infused seltzer brand Herbal Oasis announced today that at the Company's annual meeting of shareholders held on April 10, 2025, that its Common Stock holders and 8% Series A Cumulative Convertible Preferred Stock (the "Preferred Stock") holders approved the automatic conversion (the "Conversion") of shares of the Company's Preferred Stock into shares of the Comp
Charlotte, North Carolina--(Newsfile Corp. - April 8, 2025) - Herbal Oasis ("Oasis"), the hemp derived THC-infused social seltzer brand redefining how people connect, unwind, and celebrate life, is proud to announce that starting in late March, Oasis began arriving on shelves across Alabama and select counties in the Florida Panhandle, making it easier for people to grab Oasis's premium, alcohol-free beverage made for presence, clarity, and connection.A New Era of Social BeveragesOasis, a hemp derived THC-infused social seltzer, is designed to redefine how people connect, unwind, and celebrate life. Crafted for the sober-curious, health-conscious, and socially active, Oasis combines he
FSA Publishes Safety Assessment for cbdMD's Proprietary CBD IngredientCharlotte, North Carolina--(Newsfile Corp. - April 7, 2025) - cbdMD, Inc. (NYSE:YCBD) (NYSE:YCBDPA), a leader in premium hemp-derived cannabidiol (CBD) products, proudly announces that its Novel Food dossier (RP793) has advanced to the last phase of regulatory assessment with the UK Food Standards Agency (FSA), nearing final approval. This milestone not only underscores cbdMD's commitment to safety, quality, and scientific excellence but also reflects its position as a trusted brand in the growing CBD market, offering consumers confidence in purchasing compliant and rigorously tested products.cbdMD initiated this process i
Charlotte, North Carolina--(Newsfile Corp. - February 13, 2025) - (NYSE:YCBD) (NYSE:YCBDPA), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with its new functional mushroom brand ATRx Labs today announced our financial results for the first quarter of fiscal year ended December 31, 2024. The Company started fiscal 2025 with a historic quarter, achieving sequential revenue growth, positive net income and, although a loss from operations, the first ever quarter of positive non-GAAP Adjusted EBITDA. The Company generated Net Income of $15,000, an approximate $1 million improvement from the prior